Previous 10 | Next 10 |
Horizon Discovery Group plc to Present at 38 th Annual J.P. Morgan Healthcare Conference Cambridge, UK, 18 December 2019: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or “the Group”), a global leader in the application of gene editing and gene modulation techn...
Summit Therapeutics plc (‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended 31 October 2019 Oxford, UK, and Cambridge, MA, U...
LONDON, UK / ACCESSWIRE / December 17, 2019 / Condor Gold (AIM:CNR)(TSX:COG) announces that Condor S.A., its wholly-owned subsidiary in Nicaragua, is selling the non-core Potrerillos exploration and exploitation concession ("Potrerillos Concession"), to Nicoz Resources S.A., a wholly-owned ...
LONDON, UK / ACCESSWIRE / December 16, 2019 / Midatech (AIM:MTPH)(NASDAQ:MTP), an R&D biotechnology company focused on delivering innovative oncology and rare disease products, announces that it received written notification (the "Notification Letter") from The NASDAQ Stock Market LLC (...
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics to Report Financial Results for the Third Quarter and Nine Months Ended 31 October 2019 on 17 December 2019 Oxford, UK, and Cambridge, MA, US, 16 December 2019 – Sum...
Calgary, Alberta and Houston, Texas--(Newsfile Corp. - December 16, 2019) - PetroTal Corp. (TSXV: TAL) (AIM: PTAL) (" PetroTal " or the " Company ") is pleased to provide an update on its operations and production at the Bretaña oil field in Block 95 in Peru (100% working interes...
TORONTO, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (the “ Company ”), the AIM and TSXV quoted gold producer and explorer with a 100% interest in Northern Ireland’s Omagh gold mine, announces a Convertible Debenture for GBP£1,000,000 /CAD$1,731,190...
For immediate release 16 December 2019 Serabi Gold plc (“Serabi” or the “Company”) Change of Business Address Serabi Gold plc (AIM:SRB, TSX:SBI), the Brazilian ...
Calgary, Alberta and Houston, Texas--(Newsfile Corp. - December 13, 2019) - PetroTal Corp. (TSXV: TAL) (AIM: PTAL) (" PetroTal " or the " Company ") announces the grant of performance share units ("PSUs") to officers and employees of the Company. The Company has granted an aggregate of 8,441...
All arms met all primary endpoints against baseline, showing strong efficacy, safety, and rapid speed of onset However, MED2005 did not meet primary endpoints versus placebo Based on statistically significant, results compared against baseline, Futura intends to discuss a potent...
News, Short Squeeze, Breakout and More Instantly...
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of new pre-clinical data concerning the company’s drug Ampligen as part of a combinational therapy in the...
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Con...
OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series ...